Consensus-based statements for the management of mitochondrial stroke-like episodes

Yi Shiau Ng, Laurence A Bindoff, Gráinne S Gorman, Rita Horvath, Thomas Klopstock, Michelangelo Mancuso, Mika H Martikainen, Robert Mcfarland, Victoria Nesbitt, Robert D S Pitceathly, Andrew M Schaefer, Doug M Turnbull, Yi Shiau Ng, Laurence A Bindoff, Gráinne S Gorman, Rita Horvath, Thomas Klopstock, Michelangelo Mancuso, Mika H Martikainen, Robert Mcfarland, Victoria Nesbitt, Robert D S Pitceathly, Andrew M Schaefer, Doug M Turnbull

Abstract

Background: Focal-onset seizures and encephalopathy are prominent features of a stroke-like episode, which is a severe neurological manifestation associated with subtypes of mitochondrial disease. Despite more than 30 years of research, the acute treatment of stroke-like episodes remains controversial. Methods: We used the modified Delphi process to harness the clinical expertise of a group of mitochondrial disease specialists from five European countries to produce consensus guidance for the acute management of stroke-like episodes and commonly associated complications. Results: Consensus on a new definition of mitochondrial stroke-like episodes was achieved and enabled the group to develop diagnostic criteria based on clinical features, neuroimaging and/or electroencephalogram findings. Guidelines for the management of strokelike episodes were agreed with aggressive seizure management strongly recommended at the outset of stroke-like episodes. Conclusions: Our consensus statement defines stroke-like episodes in terms of an epileptic encephalopathy and we have used this to revise both diagnostic criteria and guidelines for management. A prospective, multi-centre, randomised controlled trial is required for evaluating the efficacy of any compound on modifying the trajectory of stroke-like episodes.

Keywords: MELAS; POLG; antiepileptic drugs; encephalopathies; epilepsy; m.3243A>G; neurodegenerative disorders (other than dementia); status epilepticus; stroke.

Conflict of interest statement

No competing interests were disclosed.

Copyright: © 2019 Ng YS et al.

Figures

Figure 1.. Definition, clinical features and diagnostic…
Figure 1.. Definition, clinical features and diagnostic criteria of stroke-like episodes.
(A) Consensus-based definition of mitochondrial stroke-like episode and diagnostic criteria. (B) A list of neurological signs and symptoms associated with stroke-like episodes. (C) MRI head FLAIR-sequence (i) shows typical stroke-like lesions (confluent cortical and subcortical hyperintensities) involving bilateral parietal lobes with restricted diffusion demonstrated in the right parietal lobe (ii). This patient who has the m.3243A>G-related MELAS syndrome presented with subacute-onset intermittent speech arrest, confusion and focal motor seizures affecting left arm and leg. (D) The electroencephalogram (EEG) of the same patient shows a well-formed and symmetrical 8–9Hz alpha rhythm intermixed with a large amount of diffuse theta wave in the temporal areas. A persistent sharp/spike and slow wave focus is seen over the right central electrodes (dotted-line red boxes), corresponding with the stroke-like lesion in the right parietal area identified on the MRI scan.

References

    1. Pavlakis SG, Phillips PC, DiMauro S, et al. : Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16(4):481–488. 10.1002/ana.410160409
    1. Hirano M, Ricci E, Koenigsberger MR, et al. : Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord. 1992;2(2):125–135. 10.1016/0960-8966(92)90045-8
    1. Marques-Matos C, Reis J, Reis C, et al. : Mitochondrial Encephalomyopathy With Lactic Acidosis and Strokelike Episodes Presenting Before 50 Years of Age: When a Stroke Is Not Just a Stroke. JAMA Neurol. 2016;73(5):604–606. 10.1001/jamaneurol.2015.5061
    1. Minamoto H, Kawabata K, Okuda B, et al. : Mitochondrial encephalomyopathy with elderly onset of stroke-like episodes. Intern Med. 1996;35(12):991–995. 10.2169/internalmedicine.35.991
    1. Aurangzeb S, Vale T, Tofaris G, et al. : Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) in the older adult. Pract Neurol. 2014;14(6):432–436. 10.1136/practneurol-2014-000853
    1. Goto Y, Nonaka I, Horai S: A mutation in the tRNA Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990;348(6302):651–653. 10.1038/348651a0
    1. Goto Y, Horai S, Matsuoka T, et al. : Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology. 1992;42(3 Pt 1):545–550. 10.1212/wnl.42.3.545
    1. Shanske S, Coku J, Lu J, et al. : The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. Arch Neurol. 2008;65(3):368–372. 10.1001/archneurol.2007.67
    1. Deschauer M, Tennant S, Rokicka A, et al. : MELAS associated with mutations in the POLG1 gene. Neurology. 2007;68(20):1741–1742. 10.1212/01.wnl.0000261929.92478.3e
    1. Tzoulis C, Neckelmann G, Mørk SJ, et al. : Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes. Brain. 2010;133(Pt 5):1428–1437. 10.1093/brain/awq067
    1. Engelsen BA, Tzoulis C, Karlsen B, et al. : POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain. 2008;131(Pt 3):818–828. 10.1093/brain/awn007
    1. Tzoulis C, Bindoff LA: Acute mitochondrial encephalopathy reflects neuronal energy failure irrespective of which genome the genetic defect affects. Brain. 2012;135(Pt 12):3627–3634. 10.1093/brain/aws223
    1. Ohama E, Ohara S, Ikuta F, et al. : Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol. 1987;74(3):226–233. 10.1007/bf00688185
    1. Koga Y, Akita Y, Nishioka J, et al. : L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology. 2005;64(4):710–712. 10.1212/01.WNL.0000151976.60624.01
    1. Naini A, Kaufmann P, Shanske S, et al. : Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox". J Neurol Sci. 2005;229–230:187–193. 10.1016/j.jns.2004.11.026
    1. El-Hattab AW, Adesina AM, Jones J, et al. : MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015;116(1–2):4–12. 10.1016/j.ymgme.2015.06.004
    1. Ooiwa Y, Uematsu Y, Terada T, et al. : Cerebral blood flow in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Stroke. 1993;24(2):304–309. 10.1161/01.str.24.2.304
    1. Kim JH, Lim MK, Jeon TY, et al. : Diffusion and perfusion characteristics of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode) in thirteen patients. Korean J Radiol. 2011;12(1):15–24. 10.3348/kjr.2011.12.1.15
    1. Ito H, Mori K, Kagami S: Neuroimaging of stroke-like episodes in MELAS. Brain Dev. 2011;33(4):283–288. 10.1016/j.braindev.2010.06.010
    1. Tzoulis C, Henriksen E, Miletic H, et al. : No evidence of ischemia in stroke-like lesions of mitochondrial POLG encephalopathy. Mitochondrion. 2017;32:10–15. 10.1016/j.mito.2016.11.004
    1. Iizuka T, Sakai F, Suzuki N, et al. : Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology. 2002;59(6):816–824. 10.1212/wnl.59.6.816
    1. Iizuka T, Sakai F, Kan S, et al. : Slowly progressive spread of the stroke-like lesions in MELAS. Neurology. 2003;61(9):1238–1244. 10.1212/01.wnl.0000091888.26232.fe
    1. Lax NZ, Grady J, Laude A, et al. : Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease. Neuropathol Appl Neurobiol. 2016;42(2):180–193. 10.1111/nan.12238
    1. Koenig MK, Emrick L, Karaa A, et al. : Recommendations for the Management of Strokelike Episodes in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes. JAMA Neurol. 2016;73(5):591–594. 10.1001/jamaneurol.2015.5072
    1. Parikh S, Goldstein A, Karaa A, et al. : Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2017;19(12):1380. 10.1038/gim.2017.107
    1. Kitamura M, Yatsuga S, Abe T, et al. : L-Arginine intervention at hyper-acute phase protects the prolonged MRI abnormality in MELAS. J Neurol. 2016;263(8):1666–1668. 10.1007/s00415-016-8069-4
    1. Whittaker RG, Devine HE, Gorman GS, et al. : Epilepsy in adults with mitochondrial disease: A cohort study. Ann Neurol. 2015;78(6):949–957. 10.1002/ana.24525
    1. Kaufman KR, Zuber N, Rueda-Lara MA, et al. : MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: case analysis with literature review. Epilepsy Behav. 2010;18(4):494–497. 10.1016/j.yebeh.2010.05.020
    1. Lee HN, Eom S, Kim SH, et al. : Epilepsy Characteristics and Clinical Outcome in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS). Pediatr Neurol. 2016;64:59–65. 10.1016/j.pediatrneurol.2016.08.016
    1. Tschampa HJ, Urbach H, Greschus S, et al. : Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation. J Neurol. 2013;260(4):1071–1080. 10.1007/s00415-012-6763-4
    1. Lax NZ, Gorman GS, Turnbull DM: Review: Central nervous system involvement in mitochondrial disease. Neuropathol Appl Neurobiol. 2017;43(2):102–118. 10.1111/nan.12333
    1. Dalkey N, Helmer O: An Experimental Application of the DELPHI Method to the Use of Experts. Manage Sci. 1963;9(3):351–515. 10.1287/mnsc.9.3.458
    1. Jorm AF: Using the Delphi expert consensus method in mental health research. Aust N Z J Psychiatry. 2015;49(10):887–97. 10.1177/0004867415600891
    1. Eubank BH, Mohtadi NG, Lafave MR, et al. : Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. BMC Med Res Methodol. 2016;16:56. 10.1186/s12874-016-0165-8
    1. Ng YS, Bindoff L, Gorman G, et al. : Ng et al. Consensus-based Statements for The Management of Mitochondrial Stroke-like Episodes. figshare.Dataset.2019. 10.25405/data.ncl.10740917
    1. Mancuso M, McFarland R, Klopstock T, et al. : International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy. Neuromuscul Disord. 2017;27(12):1126–1137. 10.1016/j.nmd.2017.08.006
    1. Parke TJ, Stevens JE, Rice AS, et al. : Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ. 1992;305(6854):613–6. 10.1136/bmj.305.6854.613
    1. Kraut JA, Madias NE: Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010;6(5):274–85. 10.1038/nrneph.2010.33
    1. Kaufmann P, Engelstad K, Wei Y, et al. : Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology. 2006;66(3):324–30. 10.1212/01.wnl.0000196641.05913.27
    1. Ng YS, Feeney C, Schaefer AM, et al. : Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination. Ann Neurol. 2016;80(5):686–692. 10.1002/ana.24736

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner